Therefore, our goal in this study was to evaluate the clinical characteristics and risk factors for in-hospital mortality in non-listed LC patients receiving CRRT. Clinical outcomes for this high-risk population in Korea are lacking. Literature on LC patients with AKI is difficult to generalize because of the variability in regional practice patterns and available medical treatment options such as terlipressin. Furthermore, use of different inclusion criteria for AKI staging complicates comparison of study findings. ![]() Although some studies have analyzed mortality rates according to AKI type, the results have been inconsistent. Since the International Club of Ascites Criteria for AKI (ICA-AKI) staging system was adopted, several studies have reported that mortality rate increases with AKI staging. Efforts have recently been made to explore the clinical outcomes of LC patients with AKI. However, the widespread use of CRRT has resulted in cirrhotic patients undergoing CRRT in the form of acute KRT. ![]() Due to the lack of outcome data for noncandidates for liver transplantation with AKI undergoing KRT, it is difficult to determine whether KRT should be offered to these non-listed patients. Providing KRT to acute tubular necrosis (ATN) patients who suffer multiple organ failure has been considered inappropriate. Traditionally, KRT has been considered to be a bridging therapy in patients with hepatorenal syndrome (HRS) who are possible candidates for liver transplantation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |